<code id='1CA399C0FC'></code><style id='1CA399C0FC'></style>
    • <acronym id='1CA399C0FC'></acronym>
      <center id='1CA399C0FC'><center id='1CA399C0FC'><tfoot id='1CA399C0FC'></tfoot></center><abbr id='1CA399C0FC'><dir id='1CA399C0FC'><tfoot id='1CA399C0FC'></tfoot><noframes id='1CA399C0FC'>

    • <optgroup id='1CA399C0FC'><strike id='1CA399C0FC'><sup id='1CA399C0FC'></sup></strike><code id='1CA399C0FC'></code></optgroup>
        1. <b id='1CA399C0FC'><label id='1CA399C0FC'><select id='1CA399C0FC'><dt id='1CA399C0FC'><span id='1CA399C0FC'></span></dt></select></label></b><u id='1CA399C0FC'></u>
          <i id='1CA399C0FC'><strike id='1CA399C0FC'><tt id='1CA399C0FC'><pre id='1CA399C0FC'></pre></tt></strike></i>

          knowledge

          knowledge

          author:focus    Page View:669
          Good CEOs 2022
          Hyacinth Empinado/STAT

          It’s that time of the year again when I recognize the Best Biopharma CEO of the year.

          This year’s selection is so deservingly obvious that I won’t fabricate suspense by starting with an honor roll of runners-up. More on those high-achieving folks later. Let’s get right to the main course: David Ricks of Eli Lillyis the runaway, rock star, who-else-could-it-be Best Biopharma CEO of 2023.

          advertisement

          What an incredible year it’s been for Ricks and the Lilly executive team who helped him achieve so much. My colleague Matt Herper wrote earlier this year about the “dynamic duo” of Ricks and Chief Scientific Officer Dan Skovronsky.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO
          Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

          MollyFerguson/STATThisweek,apreviewoftheTUDCAstudyinALSandthoughtsonhowitmightimpactAmylyxPharmaceut

          read more
          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more

          Congress might make insulin pumps more accessible to the blind

          AdobeKatieKeimwasdiagnosedwithtype1diabetesin1967whenshewaseight,wellbeforetheeraofinsulinpumpsoreve